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ABSTRACT
Objectives: To assess the level MMP-9, TIMP-1 and TGF-β in placental and cervical region of amniotic membranes derived 
from at-term, pre-term and PROM deliveries.
Material and methods: 14 amniotic membranes have been assessed; the quantitative analysis of MMP-9, TGF-β and 
TIMP-1 was assayed using respective Quantikine Immunoassay Kit.
Results: The MMP-9 level in PROM samples was similar to the level of MMP-9 in at-term membranes and comparable 
between the cervical and placental region of these membranes. The concentration of TGF-β and TIMP-1 was decreased in 
the cervical area of AM derived from deliveries complicated with PROM.
Conclusion: The MMP9/TIMP-1 imbalance, as well as the reduced level of TGF-β may be possible risk factors of pre-term 
labor and PROM.
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INTRODUCTION
The premature rupture of fetal membranes (PROM) is 
one of the mechanisms leading to pre-term delivery that 
is a well-known risk factor for the increased morbidity and 
mortality of the neonates [1]. It is postulated that the amnion 
rupture is not only the consequence of a simple stretching by 
mechanical forces caused by contracting uterus. It is consid-
ered rather as a biologically programmed process of the histo- 
logical remodeling leading to membrane weakening [2]. 
Studies conducted by different authors led to the conclu-
sion that the amniotic membrane is not a homogenous 
tissue and that at least two different areas of the amnion: 
placental and cervical (apical), can be distinguished [3, 4]. 
The placental region, the area distant from the uterine cervix, 
that covers the placenta, is the thickest part of the amnion, 
particularly resistant to stretch forces. The cervical area, 
often described as a ”zone of extreme morphology” is the 
region overlying the cervix, where amnion ruptures prior 
to delivery. Several studies have confirmed that this region 
contains less epithelial cells and is significantly thinner and 
weaker than the rest of AM [5, 6]. Physiological mechanisms 
involved in AM weakening in a course of gestation remain 
unknown [7–9]. Nevertheless, it has been postulated that 
biologically active factors responsible for extracellular matrix 
(ECM) turnover, especially matrix metalloproteinases (MMPs) 
and their inhibitors play a crucial role in this process. MMPs 
belong to a large family of zinc endoproteinases. They are 
able to cleave main ECM components, including collagens, 
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elastin, fibronectin, gelatin and aggrecan. MMP-9, or gelati-
nase B, is mainly produced by macrophages and neutro-
phils. Subsequently to proteolytic activation by a variety of 
factors, including plasminogen activators and other MMPs 
(MMP-2, -3, -12), MMP-9 displays elastolytic, collagenolytic 
and gelatinolytic activity [10]. Whereas some matrix metal-
loproteinases, as MMP-2 are produced constitutively in fetal 
membranes, the production and release of MMP-9 increase 
under specific conditions, such as inflammation and the 
onset of labor [11]. The role of inflammation in the release 
of the proteolytic enzymes and ECM degradation should 
be taken into consideration, nevertheless some cases of 
PROM are not related to any intrauterine infection [12]. 
Therefore, it is plausible that other mechanisms may be 
involved in the premature membrane weakening. The family 
of tissue inhibitors of metalloproteinases (TIMPs) consists 
of four protease inhibitors, secreted by different types of 
cells, like macrophages, vascular smooth muscle cells and 
platelets. They suppress the MMPs activity by binding to 
their catalytic domain and blocking enzymatic proper-
ties [13]. Another cytokine that plays an important role in 
the regulation of MMPs activity and extracellular matrix 
remodeling is transforming growth factor β (TGF-β) [14]. 
It is plausible that changes in the level of these cytokines 
may lead to the increase of MMP proteolytic activity and 
lead to the AM rupture. In our previous study, concerning 
AM obtained after physiological deliveries at term, we have 
shown that the content of TIMP-1, as well as TGF-β is differ-
ent in placental and cervical region of the AM [15]. There is 
a limited number of studies concerning TIMP-1 and TGF-β 
content in AM derived from pre-term deliveries or preg-
nancies complicated with PROM and the results remain 
inconsistent [16, 17]. Moreover, none of these studies take 
into consideration the differences between placental and 
cervical area of the membrane.
OBJECTIVES
The aim of our present study was to investigate the level 
MMP-9, TIMP-1 and TGF-β in placental and cervical region 
of amniotic membrane samples derived from at-term and 
pre-term deliveries as well as deliveries complicated with 
PROM.
MATERIAL AND METHODS
Amniotic membrane samples collection  
and preparation
14 membranes have been collected in the Department 
of Obstetrics and Gynecology of Warsaw Medical University 
Hospital. 6 AM originated from at-term physiological deliver-
ies, 5 AM from pre-term deliveries and 3 AM from deliveries 
complicated with PROM. A pre-term delivery was defined 
as a completed labor that started before 37 weeks of preg-
nancy. PROM was defined as a rupture of membranes in 
a patient who was beyond 37 weeks’ gestation, prior to the 
onset of labor (uterine contractions leading to changes in 
the cervix). Additionally, clinical data about past obstetric 
history, comorbidities, medications and infections during 
present pregnancy have been collected for each patient. 
Written informed consent was obtained from all donors of 
amnion samples. The concept of the study was reviewed 
and approved by the local bioethics committee. The study 
procedures conformed to the ethical guidelines of the World 
Medical Association Declaration of Helsinki.
From each amniotic membrane sample a cervical and 
placental portion has been separated, according to the 
method described previously. Small fragments of approxi-
mately 1 cm2 have been used to prepare amniotic mem-
brane extracts. Samples were immersed in phosphate-buff-
ered saline (PBS) with 1% Triton X-100 and a mixture of broad 
range protease inhibitors (Complete Mini, Roche Diagnos-
tics, Mannheim, Germany) and mechanically dispersed using 
glass homogenizer. The obtained suspensions have been 
centrifuged, and supernatants were transferred into fresh 
tubes, and stored until being used for further analysis.
ELISA
The quantitative analysis of MMP-9, TGF-β and TIMP-1 in 
amniotic membrane extracts was assayed using respective 
commercially available Quantikine Immunoassay (R & D 
Systems Inc. Minneapolis, USA). The level of absorbance 
for each tested sample was measured using the Microplate 
Reader 550 (BIO-RAD, Hercules, CA). The concentrations of 
respective cytokines were calculated based on correspond-
ing standard calibration curve and expressed in ng (TIMP-1, 
MMP-9) or pg (TGF-β) per mL. The assay sensitivity for each 
factor was respectively: 0.08 ng/mL for TIMP-1, 0.156 ng/mL 
for MMP-9 and 15.4 pg/mL for TGF-β.
RESULTS
The clinical characteristic of all the patients included in 
the study is presented in Table 1. 
TGF-β concentration in at-term, pre-term 
delivery and PROM-derived membranes
TGF-β was present in all tested amnion samples (Fig. 1A).
The mean concentration of TGF-β in extracts pre-
pared from pre-term labor derived membranes 
was similar between cervical and placental region: 
156 ± 184.1 pg/mL (median 57.2 pg/mL, min. 15.5 – max. 
453.9) vs. 157.5 ± 133.9 pg/mL (median 99.8 pg/mL, min. 
70 – max. 391.7) respectively. Mean concentration of 
TGF-β was 115.5 ± 108.7 pg/mL (median 64 pg/mL, min. 
18.9 – max. 266.6) in placental region, vs. 119.8 ± 96.5 pg/mL 
(median 100.2 pg/mL, min. 31.7 – max. 289.6) in cervical 
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Table 1. Clinical characteristics of all patients included in the study
Pre-term labor PROM At-term labor
Median maternal age
29 years (26–38) 32 years (29–32) 33.5 years (26–37)
Median gestational age
36 Hbd (34–36) 38 Hbd (37–39) 39.5 Hbd (37–40)
Pap test result
Normal 1 1 2
ASCUS* 2 2 3
Not known 2 0 1
GBS** test result
Positive 1 0 0
Negative 3 3 6
Not known 1 0 0
Other confirmed local infections
Mycotic 1 0 0
None 4 3 6
Reason for pre-term labor
Signs of fetal hypoxia 1
– –Pre-eclampsia 1
Not known 3
*Atypical squamous cells of undetermined significance 
**Group B Streptococcus
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Figure 1. The concentration of MMP-9 and TIMP-1 in 
amniotic membrane extracts was expressed in ng/mL, and 
TGF-β in pg/mL. Each dot represents the result of respective 
measurement in one individual amnion sample, white dots 
represent placental portions of each membrane, whereas 
black dots represent cervical portions of each membrane. 
Mean values of MMP-9, TIMP-1 and TGF-β concentration in 
each group were indicated as dashed lines, the median values 
were shown as solid lines
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region. The mean concentration of TGF-β in placental 
region of PROM samples was 116.8 ± 106.5 pg/mL (me-
dian 94.6 pg/mL, min. 23.1 – max. 232.6). The level of TGF-β 
in cervical region of these membranes was 20.3 ± 2.2 pg/mL 
(median 20.6 pg/mL, min. 18.0 – max. 22.3). 
MMP-9 concentration in at-term, pre-term 
delivery and PROM-derived membranes
The quantitative analysis using ELISA tests has con-
firmed the presence of MMP-9 in all tested AM samples 
(Fig. 1B). 
The mean concentration of MMP-9 in extracts pre-
pared from placental region of pre-term membranes was 
8.7 ± 10.0 ng/mL (median 4.9 ng/mL, min. 1.4 – max. 26.3) 
and in cervical region 16.1 ± 14.3 ng/mL (median 10.5 ng/mL, 
min. 2.7 – max. 33.7). In PROM group mean concentrations of 
MMP-9 in placental and cervical region were 3.3 ± 2.6 ng/mL 
(median 4.4 ng/mL, min. 0.3 – max. 5.3) and 1.6 ± 0.1 ng/mL 
(median 1.6 ng/mL, min. 1.5 – max. 1.7) respectively. The 
mean concentration of MMP-9 in at-term labor derived mem-
brane extracts from placental region was 5.7 ± 8.8 ng/mL 
(median 1.8 ng/mL, min. 0.9 – max. 23.4) whereas in cervical 
region 2.5 ± 1.2 ng/mL (median 2.5 ng/mL, min. 1.1 – max. 3.9).
TIMP-1 concentration in at-term, pre-term 
delivery and PROM-derived membranes
The immunoenzymatic assessment has revealed the pres-
ence of TIMP-1 in all tested samples (Fig. 1C). The mean con-
centration of TIMP-1 in pre-term labor derived membrane 
extracts from placental region was 25.2 ± 13.0 ng/mL (me-
dian 17.4 ng/mL, min. 15.7 – max. 45.2) whereas in cervical 
region 9.8 ± 7.7 ng/mL (median 7.6 ng/mL, min. 2.8 – max. 
22.7). In at-term derived membranes mean concentration 
of TIMP-1 was 18.3 ± 9.4 ng/mL (median 18.4 ng/mL, min. 
6.7 – max. 30) in placental region and 18.2 ± 11.3 ng/mL 
(median 18.4 ng/mL, min. 4.3 – max. 33.8) in cervical re-
gion. In PROM samples mean concentration of TIMP-1 in 
placental and cervical region was 20.3 ± 16.4 ng/mL (me-
dian 19.2 ng/mL, min. 4.5 – max. 37.3) vs. 4.5 ± 3.4 ng/mL 
(median 5.9 ng/mL, min. 0.7 – max. 7.0) respectively. 
MMP-9/TIMP-1 ratio
The MMP-9/TIMP-1 ratio was calculated for each study 
group (Fig. 2). The mean MMP-9/TIMP-1 ratio in extracts 
prepared from placental region of pre-term membranes was 
0.44 (median 0.14) and in cervical region 1.81 (median 1.62). 
In PROM group mean MMP-9/TIMP-1 ratios in placental 
and cervical region were 0.15 (median 0.12) and 0.98 (me-
dian 0.29) respectively. The mean MMP-9/TIMP-1 ratio in 
at-term labor derived membrane extracts from placental 
region was 0.32 (median 0.19) whereas in cervical region 
0.21 (median 0.16). 
DISCUSSION
The results of our proof-of-concept study have shown 
that the cervical area of pre-term derived AM is character-
ized with the reduced level of TIMP-1 and the increased level 
of MMP-9 in comparison to corresponding region of mem-
branes collected after physiological at-term deliveries. At 
the same time cervical region of PROM derived amnions 
is characterized by lower amounts of TIMP-1 and TGF-β 
than the cervical area of AM obtained from deliveries not 
complicated with PROM. Despite the limited number of 
samples included in the study this observation may help to 
explain the pathophysiological mechanisms of pre-mature 
membrane rupture. Therefore, it might be interesting to 
investigate it on a larger group of patients.
 Since the cervical area of AM is the region where the 
amnion ruptures prior to delivery and that displays different 
histological properties than the rest of the membrane, we 
hypothesized that any changes in MMP-9, TIMP-1 or TGF-β 
levels during course of gestation would predominantly 
manifest in the cervical region of the AM. The early studies 
on changes in AM tensile strength and collagen concentra-
tion failed, until the authors took into consideration the 
differences between placental and cervical portion of the 
membrane [12, 18]. In our study the level of MMP-9 in PROM 
samples was similar to the level of MMP-9 in at-term mem-
branes, whereas in pre-term group it was higher in cervical 
area in comparison to the placental region. The overall con-
tent of MMP-9 in pre-term membranes was also higher when 
compared to amnions collected after at-term physiolo- 
gical deliveries. At the same time the level of TIMP-1 was 
reduced in the cervical area of PROM as well as pre-term 
derived membranes, in comparison to the placental area. 
It was also lower than in corresponding area of membranes 
Figure 2. The correlation between MMP-9 and TIMP-1 in amniotic 
membrane extracts was expressed as a MMP-9/TIMP-1 ratio. Each dot 
represents the result of respective measurement in one individual 
amnion sample, white dots represent placental portions of each 
membrane, whereas black dots represent cervical portions of each 
membrane. Mean values of MMP-9/TIMP-1 ratio in each group were 
indicated as dashed lines, the median values were shown as solid 
lines
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obtained after physiological deliveries at-term (data from 
our previous study). Several authors have investigated the 
level of TIMP-1 in the amniotic fluid in pre-term deliver-
ies and PROM with inconsistent results [19]. Locksmith et 
al. have observed the decreased level of TIMP-1 in PROM 
samples, which was consistent with the previous study of 
Vadillo-Ortega et al. [20, 21]. Another group reported elevat-
ed TIMP-1 levels in amniotic fluid samples derived from de-
liveries complicated with PROM, nevertheless this study did 
not include MMP-9 assessment or MMP-9/TIMP-1 ratio [22]. 
The results of studies mentioned above are of a limited 
practical value since the authors did not take into account 
the heterogeneity of the AM. The results of our study show 
that significant differences in the amount of TIMP-1 between 
PROM and non-PROM membranes appear mainly in the 
cervical region of AM. Therefore, the mean concentration 
of this factor assessed in a membrane as a whole, may not 
reflect the real variances between samples derived from 
pre-term and at-term ruptured membranes. Moreover, the 
concentration of TIMP-1 in the amniotic fluid depends not 
only on its presence in the AM but also on placental and 
fetal secretion of this factor. 
It has been proven that in pathological processes 
a physiological balance between MMPs and TIMPs is dis-
turbed, that as a consequence leads to the impaired ECM 
turnover [12]. Therefore, the MMP-9/TIMP-1 ratio might be 
a better indicator of ECM remodeling than an absolute level 
of MMP-9 or TIMP-1 in the assessed tissue sample. In our 
study in pre-term membranes study group the mean MMP-9/ 
/TIMP-1 ratio was significantly higher in cervical than in pla-
cental region of AM, which may indicate the predominance 
of ECM degradation processes over synthesis and may be 
a hallmark of membrane weakening. A similar, although not 
that strong effect was observed in PROM membranes, which 
may be a consequence of a limited number of samples as-
sessed in this study group.
The results of our study suggest, that the reduced level 
of TGF-β in the cervical area of AM may be one of the pos-
sible risk factors of premature membrane weakening. In 
our study we have observed the overall lowest amounts 
of TGF-β in the cervical area of membranes collected from 
PROM-complicated deliveries. As mentioned before, TGF-β 
is a multifunctional cytokine that is known to regulate cells 
proliferation and differentiation, inﬂammation, angiogen-
esis, as well as ECM remodeling in a variety of tissues and 
organs, also during embryonic development [14]. The po-
tential role of TGF-β in human parturition has not been 
fully explained [23]. Nevertheless, since TGF-β regulates 
the inflammatory response and may have an influence on 
MMPs activity as well as TIMPs expression, it is plausible 
that its reduced level plays an important role in the creation 
of a weak zone in the cervical area of AM prior to delivery. 
The exact physiological mechanisms associated with TGF-β 
signaling that are responsible for AM weakening and sub-
sequent rupture need to be elucidated.
CONCLUSIONS
The results of our proof-of-concept study suggest that 
the MMP-9/TIMP-1 imbalance, as well as the reduced level of 
TGF- β in the cervical area of AM, may be one of possible risk 
factors of pre-mature AM rupture. The observed imbalance 
of biologically active factors concentration in the cervical 
area of pre-term and PROM membranes may help to reveal 
the physiological mechanisms that are involved in AM weak-
ening process. Nevertheless, the study was conducted on 
a limited number of samples, therefore, these interesting 
preliminary observation require further investigation, on 
a larger group of patients.
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